changing your setting. We'll assume that you are happy to receive all cookies on the BTG website.
We have a diverse portfolio of products including medical devices, pharmaceuticals, and drug-device combinations in several therapeutic areas. We continue to invest in clinical trials designed to expand the appropriate uses and geographic availability of our existing products. We also generate data to support bringing innovative new products to market – and to the patients who need them most. We are committed to demonstrating the value of our therapies to patients, physicians, payers and healthcare systems. Apart from demonstrating the safety and efficacy of our therapies, we strive to deliver clinical data able to enhance patient selection and treatment optimization.
In addition to traditional clinical trials, we design and conduct Registries, Retrospective Data Analysis, development of Patient Reported Outcome (PRO) measures and Health Economics Outcomes Research (HEOR).
*Table only includes studies currently “Recruiting” patients on www.Clinicaltrials.gov or EUdraCT. Last updated 12 December 2018
** PneumRx® Coil is also referred to as RePneu™. EKOS® is also referred to as EkoSonic®.
Select CONTINUE to proceed to the BTG website or LEAVE to learn more at BSC.com